Frailty phenotype and associated nutritional factors in a sample of Portuguese outpatients with heart failure

Data de publicação: Data Ahead of Print:

Autores da FMUP

  • Luís Filipe Ribeiro De Azevedo

    Autor

  • Emilia Da Conceição Torres Dias Moreira

    Autor

  • Lia Paula Nogueira Sousa Fernandes

    Autor

  • José Carlos De Magalhães Silva Cardoso

    Autor

Participantes de fora da FMUP

  • Valdiviesso, R.
  • Ataíde, R
  • Martins, S.
  • Borges, N.

Unidades de investigação

Abstract

Background and aim: Frailty phenotype (FP) is very common in heart failure (HF) and both syndromes worsen one another. The aim of this study is to first describe FP in a sample of Portuguese patients with HF, and to analyse its association with nutritional and clinical statuses, namely, muscle mass, obesity and functional class. Methods and results: In this cross-sectional study, a sample of 136 outpatients with HF (24-81 years, 33.8% women) were randomly selected from the appointments' listings of a HF and Transplant clinic in a Portuguese University Hospital. FP was assessed according to Fried et al. muscle mass was estimated from the mid-upper arm muscle circumference; weight status was assessed using the body mass index; HF functional classes were registered. The association between participants' characteristics and FP categories was analysed using logistic ordinal regression. The frequency of pre-frailty and frailty is 57.4% and 15.4%, respectively. Within frail individuals, 52.4% were under the age of 65. In multivariable analysis, frailty was positively associated with age 70 or older (OR = 3.44) and obesity (OR = 2.66), and negatively associated with muscle mass (OR = 0.77) and HF functional classes I (OR = 0.14) or II (OR = 0.29). Conclusion: Muscle mass seems to be an important predictor of frailty in patients with HF and should be taken into account when designing intervention plans that allow for reverting or modifying frailty and pre-frailty. Younger patients should be monitored for the presence and evolution of FP. (c) 2021 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Dados da publicação

ISSN/ISSNe:
1590-3729, 0939-4753

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES  Elsevier

Tipo:
Article
Páginas:
2391-2397
Link para outro recurso:
www.scopus.com

Citações Recebidas na Web of Science: 4

Citações Recebidas na Scopus: 5

Documentos

  • Não há documentos

Métricas

Filiações mostrar / ocultar

Keywords

  • Frailty phenotype; Heart failure; Nutritional status; Muscle mass; Obesity

Financiamento

Proyectos asociados

Bioavailability of EPA + DHA Enriched Canned Tuna and Its Acute Effects on Cardiovascular Risk Markers, in Healthy Human Volunteers (FUNCTIONALTUNA) - NCT03742492

Investigador Principal: Luís Filipe Ribeiro de Azevedo

Ensaio Clínico Académico (FUNCTIONALTUNA) . CINTESIS . 2019

Registo global de insuficiência cardíaca congestiva.

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Observacional Académico (IC_Congestiva) . 2019

Saúde mental em doentes críticos COVID-19: Implementação de um programa de monitorização activa e suporte pós-alta.

Investigador Principal: Lia Paula Nogueira Sousa Fernandes

Estudo Observacional Académico (MAPA) . 2020

This Study Tests Empagliflozin in Patients With Chronic Heart Failure With Preserved Ejection Fraction (HFpEF). The Study Looks at How Far Patients Can Walk in 6 Minutes and at Their Heart Failure Symptoms (EMPERIAL) - NCT03448406

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Ensaio Clínico Comercial (EMPERIAL) . Boehringer Ingelheim . 2020

Envolva-se com o seu coração: Promoção da adesão terapêutica com um sistema de telemonitorização para pessoas com insuficiência cardíaca crónica. (AdHeart)

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo de Intervenção Académico (AdHeart) . FCT . 2019

Sacubitril/Valsartan in everyday clinical practice: the experience of a heart failure clinic

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico (Sacubitril/Valsartan) . 2020

Trend of depression and its association with sociodemographic and clinical factors among multiple myeloma hospitalizations – a Portuguese nationwide study from 2000 to 2015

Investigador Principal: Lia Paula Nogueira Sousa Fernandes

Estudo Clínico Académico . 2020

Avaliação da aorta ascendente em doentes operados a tetralogia de Fallot: implicações no follow-up clínico e imagiológico

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2020

Hyperkalemia as a limiting factor of Neurohormonal Blockade/Modulation in everyday clinical practice

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2020

Health Tecnology Assessment of Nutrition an Food Productd - The Scientific Evidence Behind Health Claims

Investigador Principal: Luís Filipe Ribeiro de Azevedo

Estudo Clínico Académico . 2020

Comparative effectiveness of opioid therapy for the long term management of chronic non cancer pain

Investigador Principal: Luís Filipe Ribeiro de Azevedo

Estudo Clínico Académico . 2020

Reversão da remodelagem ventricular na miocardiopatia dilatada idiopática

Investigador Principal: José Carlos de Magalhães Silva Cardoso

Estudo Clínico Académico . 2019

Citar a publicação

Partilhar a publicação